![Plenary Lecture: AAV vector-mediated gene transfer for paediatric liver Università Vita-Salute San Raffaele Plenary Lecture: AAV vector-mediated gene transfer for paediatric liver Università Vita-Salute San Raffaele](https://www.unisr.it/mediaObject/unisr/imported/news/uploads/2016/09/mingozzinews/resolutions/res-l992x10000/mingozzinews.jpg)
Plenary Lecture: AAV vector-mediated gene transfer for paediatric liver Università Vita-Salute San Raffaele
![Federico Mingozzi: 'Potentially, gene therapy would be much cheaper than many other current treatments' - Biotech Spain Federico Mingozzi: 'Potentially, gene therapy would be much cheaper than many other current treatments' - Biotech Spain](http://biotech-spain.com/files/media/image/articles/2018/05/original/9963mingozziuab.jpg)
Federico Mingozzi: 'Potentially, gene therapy would be much cheaper than many other current treatments' - Biotech Spain
Myology 2019 | Federico Mingozzi et la maladie de Pompe | #FocusRecherche Federico Mingozzi, chercheur (Evry – France) livre les premiers résultats des études pré-cliniques pour la maladie de Pompe qui... | By Téléthon | Facebook
![Science for health on Twitter: "Gene therapies can truly transform people's lives, but there are some major hurdles to overcome, such as efficiency, toxicity, scalability and cost. Join us at https://t.co/3FIKj9NtNr and Science for health on Twitter: "Gene therapies can truly transform people's lives, but there are some major hurdles to overcome, such as efficiency, toxicity, scalability and cost. Join us at https://t.co/3FIKj9NtNr and](https://pbs.twimg.com/media/Ff6Jpg3WAAAD8Y6.jpg:large)
Science for health on Twitter: "Gene therapies can truly transform people's lives, but there are some major hurdles to overcome, such as efficiency, toxicity, scalability and cost. Join us at https://t.co/3FIKj9NtNr and
![Federico Mingozzi: "Translational research in the in vivo gene therapy of monogenic diseases" - YouTube Federico Mingozzi: "Translational research in the in vivo gene therapy of monogenic diseases" - YouTube](https://i.ytimg.com/vi/yDT4Clpl0Uo/maxresdefault.jpg)
Federico Mingozzi: "Translational research in the in vivo gene therapy of monogenic diseases" - YouTube
![Spark Therapeutics on Twitter: "Excited to share @nresearchnews research on a main challenge w/ #genetherapy: anti-AAV antibodies. Federico Mingozzi, Ph.D., CSO & co-authors offer findings that support a potential solution and share Spark Therapeutics on Twitter: "Excited to share @nresearchnews research on a main challenge w/ #genetherapy: anti-AAV antibodies. Federico Mingozzi, Ph.D., CSO & co-authors offer findings that support a potential solution and share](https://pbs.twimg.com/media/EZcBi3rWkAkKFpl.jpg)